Global Alzheimers Disease Therapeutics Market Research Report 2023

Report ID: 1989481 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Alzheimers Disease Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Biomarkers
        1.2.3 Cholinesterase Inhibitors
        1.2.4 NMDA Receptor Antagonists
    1.3 Market by Application
        1.3.1 Global Alzheimers Disease Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Alzheimers Disease Therapeutics Market Perspective (2017-2028)
    2.2 Alzheimers Disease Therapeutics Growth Trends by Region
        2.2.1 Alzheimers Disease Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Alzheimers Disease Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Alzheimers Disease Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Alzheimers Disease Therapeutics Market Dynamics
        2.3.1 Alzheimers Disease Therapeutics Industry Trends
        2.3.2 Alzheimers Disease Therapeutics Market Drivers
        2.3.3 Alzheimers Disease Therapeutics Market Challenges
        2.3.4 Alzheimers Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Alzheimers Disease Therapeutics Players by Revenue
        3.1.1 Global Top Alzheimers Disease Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Alzheimers Disease Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Alzheimers Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Alzheimers Disease Therapeutics Revenue
    3.4 Global Alzheimers Disease Therapeutics Market Concentration Ratio
        3.4.1 Global Alzheimers Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Alzheimers Disease Therapeutics Revenue in 2021
    3.5 Alzheimers Disease Therapeutics Key Players Head office and Area Served
    3.6 Key Players Alzheimers Disease Therapeutics Product Solution and Service
    3.7 Date of Enter into Alzheimers Disease Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimers Disease Therapeutics Breakdown Data by Type
    4.1 Global Alzheimers Disease Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Alzheimers Disease Therapeutics Forecasted Market Size by Type (2023-2028)
5 Alzheimers Disease Therapeutics Breakdown Data by Application
    5.1 Global Alzheimers Disease Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Alzheimers Disease Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Alzheimers Disease Therapeutics Market Size (2017-2028)
    6.2 North America Alzheimers Disease Therapeutics Market Size by Country (2017-2022)
    6.3 North America Alzheimers Disease Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Alzheimers Disease Therapeutics Market Size (2017-2028)
    7.2 Europe Alzheimers Disease Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Alzheimers Disease Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Alzheimers Disease Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Alzheimers Disease Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Alzheimers Disease Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Alzheimers Disease Therapeutics Market Size (2017-2028)
    9.2 Latin America Alzheimers Disease Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Alzheimers Disease Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Alzheimers Disease Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Alzheimers Disease Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Alzheimers Disease Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 F. Hoffmann-La Roche
        11.1.1 F. Hoffmann-La Roche Company Detail
        11.1.2 F. Hoffmann-La Roche Business Overview
        11.1.3 F. Hoffmann-La Roche Alzheimers Disease Therapeutics Introduction
        11.1.4 F. Hoffmann-La Roche Revenue in Alzheimers Disease Therapeutics Business (2017-2022)
        11.1.5 F. Hoffmann-La Roche Recent Development
    11.2 Merck
        11.2.1 Merck Company Detail
        11.2.2 Merck Business Overview
        11.2.3 Merck Alzheimers Disease Therapeutics Introduction
        11.2.4 Merck Revenue in Alzheimers Disease Therapeutics Business (2017-2022)
        11.2.5 Merck Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Detail
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Alzheimers Disease Therapeutics Introduction
        11.3.4 Pfizer Revenue in Alzheimers Disease Therapeutics Business (2017-2022)
        11.3.5 Pfizer Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Detail
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Alzheimers Disease Therapeutics Introduction
        11.4.4 Novartis Revenue in Alzheimers Disease Therapeutics Business (2017-2022)
        11.4.5 Novartis Recent Development
    11.5 Eisai
        11.5.1 Eisai Company Detail
        11.5.2 Eisai Business Overview
        11.5.3 Eisai Alzheimers Disease Therapeutics Introduction
        11.5.4 Eisai Revenue in Alzheimers Disease Therapeutics Business (2017-2022)
        11.5.5 Eisai Recent Development
    11.6 Actavis
        11.6.1 Actavis Company Detail
        11.6.2 Actavis Business Overview
        11.6.3 Actavis Alzheimers Disease Therapeutics Introduction
        11.6.4 Actavis Revenue in Alzheimers Disease Therapeutics Business (2017-2022)
        11.6.5 Actavis Recent Development
    11.7 Daiichi Sankyo
        11.7.1 Daiichi Sankyo Company Detail
        11.7.2 Daiichi Sankyo Business Overview
        11.7.3 Daiichi Sankyo Alzheimers Disease Therapeutics Introduction
        11.7.4 Daiichi Sankyo Revenue in Alzheimers Disease Therapeutics Business (2017-2022)
        11.7.5 Daiichi Sankyo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Alzheimers Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Biomarkers
    Table 3. Key Players of Cholinesterase Inhibitors
    Table 4. Key Players of NMDA Receptor Antagonists
    Table 5. Global Alzheimers Disease Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Alzheimers Disease Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Alzheimers Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Alzheimers Disease Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Alzheimers Disease Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Alzheimers Disease Therapeutics Market Share by Region (2023-2028)
    Table 11. Alzheimers Disease Therapeutics Market Trends
    Table 12. Alzheimers Disease Therapeutics Market Drivers
    Table 13. Alzheimers Disease Therapeutics Market Challenges
    Table 14. Alzheimers Disease Therapeutics Market Restraints
    Table 15. Global Alzheimers Disease Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Alzheimers Disease Therapeutics Market Share by Players (2017-2022)
    Table 17. Global Top Alzheimers Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimers Disease Therapeutics as of 2021)
    Table 18. Ranking of Global Top Alzheimers Disease Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Alzheimers Disease Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Alzheimers Disease Therapeutics Product Solution and Service
    Table 22. Date of Enter into Alzheimers Disease Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Alzheimers Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Alzheimers Disease Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Alzheimers Disease Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Alzheimers Disease Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Alzheimers Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Alzheimers Disease Therapeutics Revenue Market Share by Application (2017-2022)
    Table 30. Global Alzheimers Disease Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Alzheimers Disease Therapeutics Revenue Market Share by Application (2023-2028)
    Table 32. North America Alzheimers Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Alzheimers Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Alzheimers Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Alzheimers Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Alzheimers Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Alzheimers Disease Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Alzheimers Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Alzheimers Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Alzheimers Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Alzheimers Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. F. Hoffmann-La Roche Company Detail
    Table 43. F. Hoffmann-La Roche Business Overview
    Table 44. F. Hoffmann-La Roche Alzheimers Disease Therapeutics Product
    Table 45. F. Hoffmann-La Roche Revenue in Alzheimers Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 46. F. Hoffmann-La Roche Recent Development
    Table 47. Merck Company Detail
    Table 48. Merck Business Overview
    Table 49. Merck Alzheimers Disease Therapeutics Product
    Table 50. Merck Revenue in Alzheimers Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 51. Merck Recent Development
    Table 52. Pfizer Company Detail
    Table 53. Pfizer Business Overview
    Table 54. Pfizer Alzheimers Disease Therapeutics Product
    Table 55. Pfizer Revenue in Alzheimers Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 56. Pfizer Recent Development
    Table 57. Novartis Company Detail
    Table 58. Novartis Business Overview
    Table 59. Novartis Alzheimers Disease Therapeutics Product
    Table 60. Novartis Revenue in Alzheimers Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 61. Novartis Recent Development
    Table 62. Eisai Company Detail
    Table 63. Eisai Business Overview
    Table 64. Eisai Alzheimers Disease Therapeutics Product
    Table 65. Eisai Revenue in Alzheimers Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. Eisai Recent Development
    Table 67. Actavis Company Detail
    Table 68. Actavis Business Overview
    Table 69. Actavis Alzheimers Disease Therapeutics Product
    Table 70. Actavis Revenue in Alzheimers Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. Actavis Recent Development
    Table 72. Daiichi Sankyo Company Detail
    Table 73. Daiichi Sankyo Business Overview
    Table 74. Daiichi Sankyo Alzheimers Disease Therapeutics Product
    Table 75. Daiichi Sankyo Revenue in Alzheimers Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Daiichi Sankyo Recent Development
    Table 77. Research Programs/Design for This Report
    Table 78. Key Data Information from Secondary Sources
    Table 79. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Alzheimers Disease Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Biomarkers Features
    Figure 3. Cholinesterase Inhibitors Features
    Figure 4. NMDA Receptor Antagonists Features
    Figure 5. Global Alzheimers Disease Therapeutics Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Alzheimers Disease Therapeutics Report Years Considered
    Figure 9. Global Alzheimers Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Alzheimers Disease Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Alzheimers Disease Therapeutics Market Share by Region: 2021 VS 2028
    Figure 12. Global Alzheimers Disease Therapeutics Market Share by Players in 2021
    Figure 13. Global Top Alzheimers Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimers Disease Therapeutics as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Alzheimers Disease Therapeutics Revenue in 2021
    Figure 15. North America Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Alzheimers Disease Therapeutics Market Share by Country (2017-2028)
    Figure 17. United States Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Alzheimers Disease Therapeutics Market Share by Country (2017-2028)
    Figure 21. Germany Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Alzheimers Disease Therapeutics Market Share by Region (2017-2028)
    Figure 29. China Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Alzheimers Disease Therapeutics Market Share by Country (2017-2028)
    Figure 37. Mexico Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Alzheimers Disease Therapeutics Market Share by Country (2017-2028)
    Figure 41. Turkey Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Alzheimers Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. F. Hoffmann-La Roche Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2017-2022)
    Figure 44. Merck Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2017-2022)
    Figure 45. Pfizer Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2017-2022)
    Figure 46. Novartis Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2017-2022)
    Figure 47. Eisai Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2017-2022)
    Figure 48. Actavis Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2017-2022)
    Figure 49. Daiichi Sankyo Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2017-2022)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
F. Hoffmann-La Roche
Merck
Pfizer
Novartis
Eisai
Actavis
Daiichi Sankyo
Frequently Asked Questions
Alzheimers Disease Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Alzheimers Disease Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Alzheimers Disease Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Ammonium Alginate

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Ammonium Carbamate

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More